Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes.

Annals of surgical oncology - 1 May 2020

Mateo Alina M, Mazor Anna M, Obeid Elias, Daly John M, Sigurdson Elin R, Handorf Elizabeth A, DeMora Lyudmila, Aggon Allison A, Bleicher Richard J

Abstract excerpt

BACKGROUND: Characterization of breast cancer phenotypes has improved our ability to predict breast cancer behavior. Triple-negative (TN) breast cancers have higher and earlier rates of distant events. It has been suggested that this behavior necessitates treating TNs faster than others, including use of neoadjuvant chemotherapy (NACT) if time to surgery is not rapid. METHODS: A review of women diagnosed with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Mastectomy

Share to Neoadjuvant Therapy

Share to Survival Analysis

Share to Triple Negative Breast Neoplasms

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 31712923
DOI: 10.1245/s10434-019-08050-y
PMCID: PMC7145740

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes.PMID 31712923Read ↗

The role of tumor phenotype in the surgical treatment of early-stage breast cancer.Semantic proximity Read ↗

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.Semantic proximity Read ↗

Perioperative genetic testing and time to surgery in patients with breast cancer.Semantic proximity Read ↗

Neoadjuvant Chemotherapy in early-stage breast cancer: the trend over time and the impact on axillary management, A National Cancer Database AnalysisSemantic proximity Read ↗

Long-term Results of the Expanded Application of the ACOSOG Z0011 Trial for Patients with Breast CancerSemantic proximity Read ↗

Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.Semantic proximity Read ↗

Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.Semantic proximity Read ↗

Patterns of management of positive sentinel lymph nodes in breast cancer patients after the American College of Surgeons Oncology Group Z0011 trial: a retrospective cohortSemantic proximity Read ↗

Prognostic impact of triple negative phenotype in conservatively treated breast cancer.Semantic proximity Read ↗

Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.Semantic proximity Read ↗

Association between delayed surgery and survival in early-stage cervical cancer in mainland China: Implications during the coronavirus pandemicSemantic proximity Read ↗

Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.